Back to Search Start Over

Breast cancer risk, worry, and anxiety: Effect on patient perceptions of false-positive screening results.

Authors :
Lee JM
Lowry KP
Cott Chubiz JE
Swan JS
Motazedi T
Halpern EF
Tosteson ANA
Gazelle GS
Donelan K
Source :
Breast (Edinburgh, Scotland) [Breast] 2020 Apr; Vol. 50, pp. 104-112. Date of Electronic Publication: 2020 Feb 13.
Publication Year :
2020

Abstract

Objective: The impact of mammography screening recall on quality-of-life (QOL) has been studied in women at average risk for breast cancer, but it is unknown whether these effects differ by breast cancer risk level. We used a vignette-based survey to evaluate how women across the spectrum of breast cancer risk perceive the experience of screening recall.<br />Methods: Women participating in mammography or breast MRI screening were recruited to complete a vignette-based survey. Using a numerical rating scale (0-100), women rated QOL for hypothetical scenarios of screening recall, both before and after benign results were known. Lifetime breast cancer risk was calculated using Gail and BRCAPRO risk models. Risk perception, trait anxiety, and breast cancer worry were assessed using validated instruments.<br />Results: The final study cohort included 162 women at low (n = 43, 26%), intermediate (n = 66, 41%), and high-risk (n = 53, 33%). Actual breast cancer risk was not a predictor of QOL for any of the presented scenarios. Across all risk levels, QOL ratings were significantly lower for the period during diagnostic uncertainty compared to after benign results were known (p < 0.05). In multivariable regression analyses, breast cancer worry was a significant predictor of decreased QoL for all screening scenarios while awaiting results, including scenarios with non-invasive imaging alone or with biopsy. High trait anxiety and family history predicted lower QOL scores after receipt of benign test results (p < 0.05).<br />Conclusions: Women with high trait anxiety and family history may particularly benefit from discussions about the risk of recall when choosing a screening regimen.<br />Competing Interests: Declaration of competing interest JML and KPL receive research support from GE Healthcare. GSG was previously a consultant for GE Healthcare until 2018.<br /> (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1532-3080
Volume :
50
Database :
MEDLINE
Journal :
Breast (Edinburgh, Scotland)
Publication Type :
Academic Journal
Accession number :
32135458
Full Text :
https://doi.org/10.1016/j.breast.2020.02.004